BioVentrix
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
120 Forbes Blvd Ste 125, Mansfield, Mass...Phone Number
(925) 830-1000Website
www.bioventrix.comRevenue
-Industry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About BioVentrix
BioVentrix is a privately held medical device company headquartered in Mansfield, MA, USA. Its mission is to improve and expand the treatments available for congestive heart failure (CHF) caused by ischemic cardiomyopathy through the development of less invasive, catheter-based approaches. Note: The Revivent TC System has received the CE Mark and is approved for sale in Europe. It is considered investigational and is not approved for sale in the United States.Explore more
BioVentrix Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioVentrix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once BioVentrix has new funding data
BioVentrix, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on BioVentrix recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BioVentrix
Click to see if BioVentrix had a recent Job posting/layoffs
Check out if BioVentrix is spiking on competitors!
Check if BioVentrix has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when BioVentrix launches new products
Recommended Actions
Reach out to Masked Content who joined BioVentrix as Masked Content
Find 2 more new buyers
Compare Similar Companies to BioVentrix
Compare insights from companies similar to BioVentrix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioVentrix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioVentrix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioVentrix.
BioVentrix financials insights
Gather financial insights about BioVentrix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Private Equity
$6.5M
Private Equity
$2M
2014
Private Equity
$12.4M
Private Equity
$14M
2016
Angel/Seed
$14.5M
2017
Private Equity
$3.3M
2020
Debt
$350K
2021
Debt
$550K
2023
Series A
$48.5M
BioVentrix Tech Stack
A closer look at the technologies used by BioVentrix
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioVentrix
Sign Up For FreeTo access detailed company insights
BioVentrix is a privately held medical device company headquartered in Mansfield, MA, USA. Its mission is to improve and expand the treatments available for congestive heart failure (CHF) caused by ischemic cardiomyopathy through the development of less invasive, catheter-based approaches. Note: The Revivent TC System has received the CE Mark and i... Read More
